IRCT20220110053685N1
招募中
3 期
Therapeutic effect of 0.5% thymolol eye drops on rosacea lesions of the face in comparison with placebo
概览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 44
概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Ability to cooperate to refer at the appointed time.
- •Ability to cooperate to necessary cooperation in taking the drug.
- •consciously understanding the consent and accepting its provisions.
- •agreeing not to breastfeed and pregnancy during the study and one month later in women of childbearing age.
- •willingness not to take other drugs during the study.
- •Have the criteria for diagnosing rosacea.
排除标准
- •Receive any research medication within 30 days prior to enrollment.
- •history of allergy to beta\-blocker,
- •pregnancy or attempt to conceive or breastfeed.
- •severe depression.
- •history of hypotension or bradycardia,
- •history of myocardial infarction or heart failure.
- •history of arrhythmia,
- •history of asthma or bronchospasm.
- •Taking any rosacea stimulant such as calcium channel blocker during the study.
- •taking alpha or beta blocker drugs.
研究者
相似试验
尚未招募
早期 1 期
sing exosome to treat severe dry eyesSevere dry eye.Dry eye syndrome of unspecified lacrimal glandH04.129IRCT20170211032503N2Vision health research center30
已完成
2 期
The effect of tacrolimus eye drop in treatment of herpetic corneal ulcerherpetic non-necrotizing stormal keratitis.Herpesviral keratitis and keratoconjunctivitisIRCT2016102429871N2Guilan University of Medical Sciences, Pro-Vice -Chancellor for research50
进行中（未招募）
不适用
Effect of timolol maleate on general structural characteristics of the cornea in patients with keratoconus (abnormal conical shape of the cornea).EUCTR2012-004410-34-ESCristina Peris Martínez
尚未招募
2 期
Clinical study on Herbal Eye dropHealth Condition 1: H538- Other visual disturbancesCTRI/2021/08/035629Rishikul Campus Uttarakhand Ayurveda Uviversity
已完成
2 期
Comparison of effect of topical ophthalmic drop tacrolimus 1% versus topical ophthalmic drop dexamethasone 1% in the treatment of patients with shield ulcerIRCT2016110630746N1Vice chancellor for research, Zahedan University of Medical Sciences20